Immunome Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Immunome Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q3 2024.
  • Immunome Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 62.4M shares, a 46.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 62.4M +19.7M +46.1% Nov 8, 2024 10-Q 2024-11-13
Q2 2024 60.1M +47.9M +392% Aug 7, 2024 10-Q 2024-08-12
Q1 2024 59.7M +47.5M +389% Mar 26, 2024 10-K 2024-03-28
Q3 2023 42.7M +30.6M +252% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 12.2M +75.1K +0.62% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 12.2M +87.6K +0.72% Mar 13, 2023 10-K 2023-03-16
Q3 2022 12.1M +28.5K +0.24% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 12.1M +313K +2.65% Aug 2, 2022 10-Q 2022-08-05
Q1 2022 12.1M +1.47M +13.8% Mar 22, 2022 10-K 2022-03-28
Q3 2021 12.1M +1.56M +14.8% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 11.8M Aug 12, 2021 10-Q 2021-08-16
Q1 2021 10.7M Mar 22, 2021 10-K 2021-03-25
Q3 2020 10.5M Oct 31, 2020 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.